Designing Early-Phase Clinical Trials for Cellular and Gene Therapy Products | BioBoston Consulting

Discover how to design early-phase clinical trials for cellular and gene therapy products. Learn about safety, tolerability, regulatory guidance, and manufacturing challenges with BioBoston Consulting.

Companies that provide consulting in quality and regulatory matter in the life science industry need to be aware of these recommendations, follow them up, and implement them. 

I.  Embracing a Paradigm Shift: The Landscape of CGT Products 

The guidance summarizes the regulatory scope of OCTGT and emphasizes that CGT products present some unique challenges. It is limited to certain products based on other regulatory domains and focuses primarily on safety, tolerability, and feasibility assessments in early-phase trials. 

II. Discerning the History: The Trade-Off between Risk and Gain 

Drawing on the unique nature of CGT products, the background section highlights unprecedented risks being seen in early-phase trials. As we will show with illustrative examples, this highlights the urgent need for such considerations in trial design, paving the way for the recommendations in this guidance. 

III. Prompt Design for CGT Products: Special Features of the Technologies 

Aspects of CGT products that influence trial design The minutiae, from extended biological activity to risk of immunogenicity are all examined. In this crucial phase, the list of complexities can be daunting and BioBoston Consulting stands ready to help sponsors navigate through. 

IV. Manufacturing Difficulties: Blowing Up the Practical Limits 

This section, which dives into the details of manufacturing, lays out some of the scientific and logistical hurdles. The article delves into practical limits on product doses, concentrations and volume with an intent to provide a roadmap for sponsors in navigating through these complexities smoothly. 

BioBoston Consulting: A lighthouse to successful early-phase clinical trials — the journey through a turbulent landscape of CGT products 

We believe that our dedication to the highest level of quality and regulatory consulting can help sponsors and investigators navigate challenges or hurdles to achieve discoveries to advance cell and gene therapies. So, as the original catalyst for change, let us all lead our transformation journey. 

Call BioBoston Consulting now or check our website to find out how we can help you with your organization.